Iodixanol Compared to Iohexol for Contrast Procedures: A Case-Matched Retrospective Cohort Study

References

• Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489–94
   PubMed Web of Science ®Google Scholar
• Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006; 354: 2773–82
   PubMed Web of Science ®Google Scholar
• McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006; 48: 692–9
   PubMed Web of Science ®Google Scholar
• Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491–9
   PubMed Web of Science ®Google Scholar
• Pugh ND, Sissons GR, Ruttley MS, Berg KJ, Nossen JO, Eide H. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 1993; 47: 96–9
   PubMedGoogle Scholar
• Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Clin Radiol 1993; 48: 268–72
   Google Scholar
• Bertrand ME, Esplugas E, Piessens J, Rasch W. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators. Circulation 2000; 101: 131–6
   PubMedGoogle Scholar
• Hill JA, Cohen MB, Kou WH, Mancini GB, Mansour M, Fountaine H, et al. Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography. Am J Cardiol 1994; 74: 57–63
   PubMedGoogle Scholar
• Klow NE, Levorstad K, Berg KJ, Brodahl U, Endresen K, Kristoffersen DT, et al. Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol 1993; 34: 72–7
   PubMedGoogle Scholar
• Jakobsen JA. Renal effects of iodixanol in healthy volunteers and patients with severe renal failure. Acta Radiol Suppl 1995; 399: 191–5
   Google Scholar
• Siegel EL, Rosenblum JD, Eckard DA, Leef J, Bergh J, Parsa MB, et al. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial. Acad Radiol 1996; 3(Suppl 3)S507–13
   Google Scholar
• Liss P, Persson P, Hansell P, Lagergvist B. Renal failure in 57925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006; 70: 1811–7
   PubMed Web of Science ®Google Scholar
• McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368–75
   PubMed Web of Science ®Google Scholar
• Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983; 74: 243–8
   PubMed Web of Science ®Google Scholar
• Pannu N, Wiebe N, Tonelli M, Alberta Kidney Disease Network. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765–79.
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Rebeiz AG, Wang A, Sketch MH, Jr. Contrast nephropathy: an evidence-based approach to prevention. Am J Cardio Drug 2003; 3: 395–405
   PubMedGoogle Scholar
• Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763–71
   PubMed Web of Science ®Google Scholar
• Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328–34
   PubMed Web of Science ®Google Scholar
• Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251–9
   PubMed Web of Science ®Google Scholar
• Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292: 344–50
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–70
   PubMed Web of Science ®Google Scholar
• Poggio ED, Wang X, Weinstein DM, Issa N, Dennis VW, Braun WE, et al. Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am J Transpl 2006; 6: 100–8
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1–266.
   PubMed Web of Science ®Google Scholar
• Grossman RI, Modic MT. A randomized comparison of iodixanol and iohexol in adult intracranial computed tomography scanning. Acad Radiol 1996; 3(Suppl 3)S488–94
   Google Scholar
• Verow P, Nossen JO, Sheppick A, Kjaersgaard P. A comparison of iodixanol with iopamidol in aorto-femoral angiography. Br J Radiol 1995; 68: 973–8
   Google Scholar
• Poirier VC, Newberry PD, Hecht ST, Nemzek WR. Phase III clinical trial comparing iodixanol and iohexol in cerebral angiography. Acad Radiol 1996; 3(Suppl 3)S495–9
   Google Scholar
• Tveit K, Bolz KD, Bolstad B, Haugland T, Berg KJ, Skjaerpe T, et al. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. Acta Radiol 1994; 35: 614–8
   PubMedGoogle Scholar
• Singh K, Sundgren R, Bolstad B, Bjork L, Lie M. Iodixanol in abdominal digital subtraction angiography. A randomized, double-blind, parallel trial with iodixanol and iohexol. Acta Radiol 1993; 34: 242–5
   Google Scholar